Candel Therapeutics (CADL) Shares Issued (2020 - 2025)

Candel Therapeutics' Shares Issued history runs 5 years deep, the most recent figure standing at -$4.5 million for Q4 2025.

• In Q4 2025, Shares Issued fell 1322.16% year-over-year to -$4.5 million; the TTM figure through Dec 2025 stood at $516000.0 (down 69.45% YoY), while the FY2025 annual figure was $516000.0, down 69.45% from the prior year.
• Shares Issued came in at -$4.5 million for Q4 2025 at Candel Therapeutics, down from $4.5 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $71.3 million in Q3 2021 to a low of -$70.9 million in Q4 2021.
• A 4-year average of $192785.7 and a median of $72000.0 in 2022 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued slumped 244600.0% in 2021 and jumped 295.78% in 2025, its largest moves.
• Candel Therapeutics' Shares Issued stood at -$70.9 million in 2021, then jumped by 100.05% to $36000.0 in 2022, then jumped by 927.78% to $370000.0 in 2024, then slumped by 1322.16% to -$4.5 million in 2025.
• According to Business Quant data, Shares Issued over the past three periods registered -$4.5 million, $4.5 million, and $108000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison